title: FDA approves quadrivalent HPV vaccine for use in males ages 9-26 years.
authors.forename: Arun
authors.initials: A
authors.lastname: Garg
authors.forename: Ghislaine
authors.initials: G
authors.lastname: Guez
mesh_terms: D000293:Adolescent; D000328:Adult; D002648:Child; D017277:Drug Approval; D005260:Female; D006801:Humans; D008297:Male; D009959:Oropharyngeal Neoplasms / Q000517:prevention & control*; D030361:Papillomavirus Infections / Q000517:prevention & control*; D053918:Papillomavirus Vaccines; D014481:United States; D014486:United States Food and Drug Administration; D055815:Young Adult
chemical_list: D053918:Papillomavirus Vaccines